Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Sustainability
The Rise of ESG: Where It Is Now and How It Got Here
Calls for corporate reform are as old as the corporation itself, so why now are companies pushing for more ESG efforts in their organizations?
By
Ted Jackson
| July 5, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Gilead Sciences
M&A
Gilead to Buy Cancer Drugmaker for $21 Billion
The acquisition of Immunomedics "represents significant progress in Gilead’s work to build a strong and diverse oncology portfolio."
By
Matthew Heller
| September 14, 2020
Read More
Supply Chain
Gilead Works to ‘Maximize Global Supply’ Of Coronavirus Candidate Remdesivir
"Close coordination of remdesivir manufacturing will be critical," said Gilead Sciences.
By
Vincent Ryan
| May 6, 2020
Read More
M&A
Gilead to Buy Forty Seven for $4.9B
The deal adds to Gilead's presence in immuno-oncology, an approach to treating cancer that harnesses the body's immune system.
By
Lauren Muskett
| March 2, 2020
Read More
People
CFOs on the Move: Week Ending May 3
Home Depot, Gilead Sciences, Argonne National Lab, Globe Photos, American Water, Talos Energy, Ryan Cos., Insurance Auto Actions, VIQ Solutions, Trinseo
By
Joan Urdang
| May 3, 2019
Read More
Strategy
Gilead Flies Into Cancer Therapy With Kite Deal
The $11.9 billion acquisition gives Gilead access to the oncology market as its hepatitis C drugs face declining sales.
By
Matthew Heller
| August 28, 2017
Read More
Investment Banking
Corporate Bond Market Booming
The flurry of deals came after issuance virtually halted for nearly two weeks.
By
Katie Kuehner-Hebert
| September 10, 2015
Read More
Profiles
Quick Take: Gilead Sciences CFO Robin Washington
A biotech finance chief shares her thoughts on the CFO role.
By
Kate O'Sullivan
| July 25, 2012
Read More